Change Language
Call_us
Erlocip Tablets

Erlocip Tablets

2000 INR/Box

Product Details:

  • Assay Not less than 98%
  • Usage For treatment of non-small cell lung cancer and pancreatic cancer
  • Origin of Medicine India
  • CAS No 183321-74-6
  • Pacakaging (Quantity Per Box) 30 tablets per box
  • Indication Used for the treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer
  • Storage Store below 30C, protected from light and moisture
  • Click to View more
X

Erlocip Tablets Price And Quantity

  • 100 Tablet
  • 2000 INR/Box

Erlocip Tablets Product Specifications

  • Not less than 98%
  • For treatment of non-small cell lung cancer and pancreatic cancer
  • India
  • 183321-74-6
  • Used for the treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer
  • 30 tablets per box
  • Pharmaceutical Grade
  • Store below 30C, protected from light and moisture
  • Allopathic
  • White to off-white tablets
  • Erlotinib Hydrochloride
  • Tablet
  • 150 mg
  • 36 months from manufacturing date
  • C22H23N3O4

Erlocip Tablets Trade Information

  • Ahmedabad
  • Cash in Advance (CID), Cash Advance (CA)
  • 1000 Tablet Per Day
  • 1 Week
  • Yes
  • Within a certain price range free samples are available
  • 30 tablets in 1 strip
  • Asia, Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America

Product Description

Erlocip Tablets

Erlocip 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.



Powerful Targeted Therapy for Cancer

Erlocip Tablets are specifically formulated for the effective management of non-small cell lung cancer and pancreatic cancer. By targeting the growth of cancer cells, Erlocip offers a scientifically advanced approach for eligible patients. It is designed for oral administration, enabling convenient treatment as directed by a healthcare provider. Its pharmaceutical-grade formulation ensures consistent efficacy and patient safety when used as prescribed.


Precision Manufacturing and Assured Quality

Manufactured in India, Erlocip Tablets meet stringent pharmaceutical standards, providing an assay value of not less than 98%. Each HDPE bottle protects the tablets from moisture and light, ensuring their potency and integrity. The white to off-white tablets are crafted to maintain stability for up to 36 months, granting confidence in both quality and shelf life for distributors and healthcare professionals alike.

FAQ's of Erlocip Tablets:


Q: How should Erlocip Tablets be taken for optimal effectiveness?

A: Erlocip Tablets should be taken orally on an empty stomach, at least one hour before or two hours after food, exactly as prescribed by your doctor. Follow your healthcare provider's instructions closely for best results.

Q: What conditions are treated with Erlocip Tablets?

A: Erlocip is used for the treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer, as indicated by your physician.

Q: When should I take Erlocip Tablets during my daily routine?

A: Erlocip Tablets are usually taken once daily, at the same time each day, unless your doctor advises otherwise. Consistency helps maintain the medicine's effectiveness.

Q: Where should Erlocip Tablets be stored at home?

A: Store Erlocip Tablets below 30C, protected from light and moisture. Keep them tightly closed in their original HDPE container and out of reach of children.

Q: What is the process for getting Erlocip Tablets?

A: As a Schedule H prescription medicine, Erlocip requires a valid prescription from a licensed healthcare professional. Consult your doctor to determine if it is appropriate for your condition before obtaining it from a pharmacy or supplier.

Q: What are the main benefits of using Erlocip Tablets?

A: Erlocip Tablets provide a targeted therapy designed to inhibit cancer cell growth, potentially prolonging survival and improving quality of life in patients with specific forms of lung and pancreatic cancer.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category



trade india member
SCHWITZ BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.